Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Clonal expansion and microevolution of quinolone-resistant Salmonella enterica serotype typhi in Vietnam from 1996 to 2004.

Le TA, Fabre L, Roumagnac P, Grimont PA, Scavizzi MR, Weill FX.

J Clin Microbiol. 2007 Nov;45(11):3485-92. Epub 2007 Aug 29.

2.

Endemic, epidemic clone of Salmonella enterica serovar typhi harboring a single multidrug-resistant plasmid in Vietnam between 1995 and 2002.

Le TA, Lejay-Collin M, Grimont PA, Hoang TL, Nguyen TV, Grimont F, Scavizzi MR.

J Clin Microbiol. 2004 Jul;42(7):3094-9. Erratum in: J Clin Microbiol. 2005 Jul;43(7):3594.

3.

Antimicrobial susceptibility test: from bacterial population analysis to therapy.

Scavizzi MR, Labia R, Petitjean OJ, Elbhar A.

Int J Antimicrob Agents. 2002 Jan;19(1):9-20.

PMID:
11814763
4.

TEM-8: a paradoxical ceftazidimase that owes its uniqueness to the presence of serine residues at positions 164 and 238.

Scanvic AM, Soilleux MJ, Chaibi EB, Labia R, Scavizzi MR.

J Antimicrob Chemother. 1997 Aug;40(2):303-4. No abstract available.

PMID:
9302002
5.

In-vitro and in-vivo activities of antibiotics on Yersinia enterocolitica.

Scavizzi MR, Gayraud M, Hornstein MJ, Jupeau-Vessieres AM, Bronner FD, Elbhar A.

J Antimicrob Chemother. 1996 Dec;38(6):1108-9. No abstract available.

PMID:
9023662
6.

Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France.

Soilleux MJ, Morand AM, Arlet GJ, Scavizzi MR, Labia R.

Antimicrob Agents Chemother. 1996 Apr;40(4):1027-9.

7.

Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections.

Fournier JL, Ramisse F, Jacolot AC, Szatanik M, Petitjean OJ, Alonso JM, Scavizzi MR.

Antimicrob Agents Chemother. 1996 Feb;40(2):325-30. Erratum in: Antimicrob Agents Chemother 1996 Oct;40(10):2441.

8.

Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.

Bonacorsi SP, Scavizzi MR, Guiyoule A, Amouroux JH, Carniel E.

Antimicrob Agents Chemother. 1994 Mar;38(3):481-6. Erratum in: Antimicrob Agents Chemother 1994 Jul;38(7):1694.

9.

Antibiotic treatment of Yersinia enterocolitica septicemia: a retrospective review of 43 cases.

Gayraud M, Scavizzi MR, Mollaret HH, Guillevin L, Hornstein MJ.

Clin Infect Dis. 1993 Sep;17(3):405-10.

PMID:
8218681
10.

Multidimensional analysis for interpreting antibiotic susceptibility data.

Scavizzi MR, Elbhar A, Fénelon JP, Bronner FD.

Antimicrob Agents Chemother. 1993 Apr;37(4):929. No abstract available.

11.

In-vitro and in-vivo activities of beta-lactam antibiotics on Yersinia enterocolitica.

Hornstein MJ, Alonso JM, Elbhar A, Scavizzi MR.

J Antimicrob Chemother. 1992 Apr;29(4):456-9. No abstract available.

PMID:
1607334
12.
13.

Evidence for broken minocycline by NMR and HPLC techniques: a new additional resistance mechanism mediated by tetB determinant.

Jupeau-Vessières AN, Leroux YG, Scavizzi MR, el Manouni D, Gerbaud GR.

Res Microbiol. 1989 Mar-Apr;140(3):207-19.

PMID:
2694246
14.

Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection.

Scavizzi MR, Alonso JM, Philippon AM, Jupeau-Vessieres AM, Guiyoule A.

Antimicrob Agents Chemother. 1987 Apr;31(4):523-6.

15.

In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics.

Hornstein MJ, Jupeau AM, Scavizzi MR, Philippon AM, Grimont PA.

Antimicrob Agents Chemother. 1985 May;27(5):806-11.

16.

A rapid micromethod for the determination of the sensitivity to antibiotics of Pseudomonas aeruginosa.

Rykner G, Scavizzi MR.

J Antimicrob Chemother. 1976 Jun;2(2):217-9. No abstract available.

PMID:
821912
17.

Chelocardin-inducible resistance in Escherichia coli bearing R plasmids.

Chabbert YA, Scavizzi MR.

Antimicrob Agents Chemother. 1976 Jan;9(1):36-41.

18.

[Sensitivity of Enterobacteriaceae to colistin. Use of a micromethod].

Scavizzi MR, Rykner G.

Pathol Biol (Paris). 1974 Apr;22(4):329-35. French. No abstract available.

PMID:
4603821
19.

[Bacterial flora in aplastic anemia. Consequences on antibiotherapy].

Rykner G, Francoual C, Scavizzi MR.

Nouv Presse Med. 1973 Jul 7;2(27):1823-8. French. No abstract available.

PMID:
4198227
20.

Incompatibility groups and the classification of fi - resistance factors.

Chabbert YA, Scavizzi MR, Witchitz JL, Gerbaud GR, Bouanchaud DH.

J Bacteriol. 1972 Nov;112(2):666-75.

21.

[Determination of antibiotic minimal inhibitory concentration using a micromethod].

Rykner G, Scavizzi MR.

Pathol Biol (Paris). 1972 Nov;20(21):903-7. French. No abstract available.

PMID:
4566246
22.

[Determination of the minimal inhibiting concentration of antibiotics. Explanation of a micromethod].

Scavizzi MR, Rykner G.

Nouv Presse Med. 1972 Jul 22;1(29):1951-2. French. No abstract available.

PMID:
5053609
23.

[Epidemiology of septicemias due to Yersinia enterocolitica].

Scavizzi MR, Rykner G, Lecouturier JP, Reboul M, Bouvier JB.

Sem Hop. 1972 Mar 20;48(14):997-8. French. No abstract available.

PMID:
4339079
24.

[Existence of 2 transferable tetracycline resistance factors].

Scavizzi MR.

Ann Inst Pasteur (Paris). 1972 Jan;122(1):3-17. French. No abstract available.

PMID:
4625137
25.

[A sporadic case of cholera: the problem of rapid bacteriological diagnosis].

Scavizzi MR, Dodin A, Ryckner G, Wiart J.

Med Trop (Mars). 1971 Jan-Feb;31(1):55-8. French. No abstract available.

PMID:
4930663
26.

[Study of the transferability of resistance factors in enteropathogenic E. coli during nursery epidemics].

Scavizzi MR, Chabbert YA.

Pathol Biol (Paris). 1970 Dec;18(23):1079-87. French. No abstract available.

PMID:
4923598
27.

Elimination by ethidium bromide of antibiotic resistance in enterobacteria and staphylococci.

Bouanchaud DH, Scavizzi MR, Chabbert YA.

J Gen Microbiol. 1968 Dec;54(3):417-25. No abstract available.

PMID:
4885039

Supplemental Content

Loading ...
Support Center